Atul Limited · NSE:ATUL
Atul — Shareholder Meeting (2021)
24 slides from Atul's shareholder meeting presentation, 2021
Slide 1: Welcome - Annual General Meeting 2021
WELCOME Annual General Meeting 2021 entry to Atul Complex
Slide 2: Pandemic
Pandemic Global impact Safe working at factories Corona virus Work from home Safe working in the offices
Slide 3: 2020-21 Financials
2020-21 Financials Sales PBT ` cr 3,824 803 773 3,460 4% 10% FY 20 FY 21 FY 20 FY 21 EBIDTA % RoCE % 26% 34% 24% 28% 2% points 6% points FY 20 FY 21 FY 20 FY 21 FY21 – excluding one-time dividend income of ` 55 cr
Slide 4: Dividend
Dividend 275% 125%* 200% 150% 120% 100% 100% 85% 75% 60% 150% 45% FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 * special dividend to commemorate 125th birth anniversary of the Founder
Slide 5: Buy-back of equity shares
Buy-back of equity shares number amount ~ 75,000 ~ ` 50 cr
Slide 6: Sales potential
Sales potential investment of improve sales of ~ ` 1,500 cr + capacity utilisation ~ ` 6,000 cr
Slide 7: Zero liquid discharge
Zero liquid discharge Atul, Ankleshwar site Atul, Tarapur site Atul, North site Atul, South site
Slide 8: Zero liquid discharge
Zero liquid discharge Anaven LLP Rudolf Atul Chemicals Ltd Atul Bioscience Ltd (Ambernath) Amal Ltd
Slide 9: Amal Ltd
Amal Ltd expansion under implementation | 2020-21 sales: ` 30 cr
Slide 10: Anaven LLP
Anaven LLP investment: ` 230 cr (commissioned in Mar 21), sales potential: ` 160 cr
Slide 11: Atul Bioscience Ltd
Atul Bioscience Ltd Ambernath investment: ` 110 cr, sales potential: ` 270 cr
Slide 12: Atul Rajasthan Date Palms Ltd
Atul Rajasthan Date Palms Ltd production under stabilisation
Slide 13: DPD Ltd
DPD Ltd investment: ` 22 cr (completed), ` 16 cr (underway), sales potential: ` 85 cr (2020-21 sales: ` 38 cr)
Slide 14: Rudolf Atul Chemicals Ltd
Rudolf Atul Chemicals Ltd completion of 10 years of partnership
Slide 15: Financials of subsidiary, joint venture and associate entities (manufacturing)
Financials of subsidiary, joint venture and associate entities (manufacturing)* ` cr 2020-21 2019-20 Revenue 303 244 EBIDTA 68 51 EBIDTA % 22% 21% PBT 46 30 PAT 35 23 Sales potential on completion of projects under implementation: ` 800 cr * Amal | Anaven | Atul Bioscience | Atul Rajasthan Date Palm
Slide 16: Performance trend
Performance trend ` cr 3,843 3,824 Sales 3,460 3,052 2,510 2,403 2,639 Growth: 180% 2,307 1,964 1,746 1,508 1,159 1,168 Growth: 129% 895 998 682 817 520 533 578 568 PBT 803 773 652 Growth: 827% 400 400 397 297 312 192 139 122 Growth: 456% 83 80 15 22 39 19 26 38 46 7 00-01 02-03 04-05 06-07 08-09 10
Slide 17: Initiatives
Initiatives People Processes Free cash flow
Slide 18: Q1 financials
Q1 financials ` cr 2021-22 2020-21 Q1 Q1 Q4 Sales 1,025 589 1,063 EBIDTA % 23% 25% 24% PBT from operations 205 117 224 PBT 210 153 226 PAT 156 117 169 RoCE % 37% 32% 44%
Slide 19: Q1 financials subsidiary, joint venture and associate entities (manufacturing)
Q1 financials subsidiary, joint venture and associate entities (manufacturing)* ` cr 2021-22 2020-21 Q1 Q1 Q4 Sales 93 48 81 EBIDTA % 12% 22% 18% PBT 6 5 9 * Amal | Anaven | Atul Bioscience | Atul Rajasthan Date Palms | DPD | Rudolf Atul Chemicals
Slide 20: Atul Foundation
Atul Foundation Online education Ankur – a project of Atul Foundation to nourish the mind and body
Slide 21: Team Atul
Team Atul
Slide 22: Key stakeholders
Key stakeholders customers communities shareholders team members suppliers
Slide 23: Stay updated
Stay updated www.facebook.com/atulltd
Slide 24: miles to go ... questions and answers
miles to go … | questions and answers |